The user facility reported to terumo cardiovascular that during cardiopulmonary bypass, approximately 2 hours into a 5 hour pump run, condensation and fluid were observed inside the end cap of the oxygenator.There was also fluid dripping around the end cap and some blood in the gas inlet line to the oxygenator.Blood loss amount is unknown.Product was not changed out.Procedure was completed successfully.
|
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on september 4, 2018.(b)(4).The sample was not returned for evaluation, however, a video showing the complaint was provided for review.A retention sample was visually inspected and did not reveal any obvious anomaly such as a break.The retention sample was also built into a circuit with tubes and saline solution was circulated in the circuit at the flow rate of 5l/min.No leak was observed.Subsequently, the circuit was circulated with bovine blood for 6 hours at the flow rate of 5l/min and at the back pressure of 500 mmhg.After the 6-hour circulation, a gas was sent into the gas phase.No leak was observed.A review of the video confirmed the event.The presence of foamy fluid was noted around the gas phase.Based on the review result of the provided video, it is likely that a plasma leak took place in the actual sample.With the absence of the actual sample to evaluate, however, it is difficult to determine the definitive cause of this complaint.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|